Drug-Eluting Sinus Stent Hits the Market: May help maintain patency after FESS

The real test, Dr. Citardi said, will be “the test of time.” “Over the next couple years, as people start to use the stent, we’ll be able to better define its role and use,” he said.

Disclosures: Dr. Freeman has reported a financial relationship with InHealth Technologies, the company that manufactures and distributes his Freeman nasal stent. Dr. Kennedy is on the medical advisory board of Intersect ENT. None of the other sources reported any relevant financial ties.